Reasons for Ineligibility in phase 1 and 2A HIV Vaccine Initiative (KAVI), Kenya

View/Open
Date
2011
Author
Omosa-Manyonyi, Gloria S.
Omu Anzala, Walter Jaoko
Ogutu, Hilda
Wakasiaka, Sabina
Malogo, Roselyn
Nyange, Jacqueline
Njuguna, Pamela
Ndinya-Achola, JO
Bhatt, Kirana
Bashir, Farah
Oyaro, Micah
Schmidt, Claudia
Priddy, Frances
Fast, Patricia
Type
Article
Language
en
Metadata
Show full item record

Abstract
With the persistent challenges towards controlling the HIV epidemic, there is an ongoing need for research into HIV vaccines and drugs. Sub-Saharan African countries - worst affected by the HIV pandemic - have participated in the conduct of clinical trials for HIV vaccines. In Kenya, the Kenya AIDS Vaccine Initiative (KAVI) at the University of Nairobi has conducted HIV vaccine clinical trials since 2001
URI
http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/10567
Citation
PLoS ONE
Publisher
School of nursing science, University of Nairobi
Subject
Aids Vaccine Initiative
Collections